VERACYTE, INC. - 8-K Filing

Veracyte reports Q3 2026 total revenue of $151.8 million (up 15% YoY) and authorizes a new $100 million share repurchase program. (Items: 2.02 Results of Operations and Financial Condition, 8.01 Other Events, 9.01 Financial Statements and Exhibits)

SEC EDGAR ·

Tickers: $VCYT

Read the full article at SEC EDGAR

Part of the story BOISE CASCADE Co - 10-Q Filing (3 articles)

More Regulatory news